1. Home
  2. ARTW vs MBIO Comparison

ARTW vs MBIO Comparison

Compare ARTW & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTW
  • MBIO
  • Stock Information
  • Founded
  • ARTW 1956
  • MBIO 2015
  • Country
  • ARTW United States
  • MBIO United States
  • Employees
  • ARTW N/A
  • MBIO N/A
  • Industry
  • ARTW Industrial Machinery/Components
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARTW Industrials
  • MBIO Health Care
  • Exchange
  • ARTW Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • ARTW 8.6M
  • MBIO 7.3M
  • IPO Year
  • ARTW N/A
  • MBIO N/A
  • Fundamental
  • Price
  • ARTW $1.74
  • MBIO $2.80
  • Analyst Decision
  • ARTW
  • MBIO Strong Buy
  • Analyst Count
  • ARTW 0
  • MBIO 1
  • Target Price
  • ARTW N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • ARTW 36.8K
  • MBIO 412.6K
  • Earning Date
  • ARTW 04-08-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • ARTW N/A
  • MBIO N/A
  • EPS Growth
  • ARTW N/A
  • MBIO N/A
  • EPS
  • ARTW N/A
  • MBIO N/A
  • Revenue
  • ARTW $25,181,639.00
  • MBIO N/A
  • Revenue This Year
  • ARTW N/A
  • MBIO N/A
  • Revenue Next Year
  • ARTW N/A
  • MBIO N/A
  • P/E Ratio
  • ARTW N/A
  • MBIO N/A
  • Revenue Growth
  • ARTW N/A
  • MBIO N/A
  • 52 Week Low
  • ARTW $1.33
  • MBIO $2.40
  • 52 Week High
  • ARTW $4.15
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • ARTW 48.27
  • MBIO 29.74
  • Support Level
  • ARTW $1.67
  • MBIO $2.40
  • Resistance Level
  • ARTW $1.91
  • MBIO $3.04
  • Average True Range (ATR)
  • ARTW 0.11
  • MBIO 0.65
  • MACD
  • ARTW 0.00
  • MBIO 0.06
  • Stochastic Oscillator
  • ARTW 45.16
  • MBIO 9.30

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: